Opens in a new tab or window Higher-potency topical corticosteroids, JAK inhibitors, and tacrolimus 0.1% were deemed the most effective topical anti-inflammatory treatments for atopic dermatitis ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

By personifying my eczema and relating to her instead of seeing her as my enemy, I started healing more quickly. I still flare up, but atopic dermatitis no longer controls what I get to do on a ...

While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...

Atopic dermatitis is the most common type of eczema, affecting approximately 9.6 million children and 16.5 million adults in the United States. ZORYVE cream 0.15% was approved by the FDA for the ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...

Long-term treatment of adolescents with moderate-to-severe atopic dermatitis with upadacitinib is safe and effective through 76 weeks.

In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.

It is not just about itchy skin: Know surprising truth about Atopic Dermatitis as Eczema is on the rise in ... has led to the development of targeted treatments, offering help for individuals ...

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

BOSTON (Oct. 24, 2024) – Parents of children with atopic dermatitis (AD, also called eczema) know that the ... diets aren’t recommended as a treatment for AD, according to guidelines from ...